Cortisone in ulcerative colitis; preliminary report on a therapeutic trial.

PubWeight™: 20.09‹?› | Rank: Top 0.1% | All-Time Top 10000

🔗 View Article (PMC 2078989)

Published in Br Med J on August 14, 1954

Authors

S C TRUELOVE, L J WITTS

Articles citing this

Cortisone in ulcerative colitis; final report on a therapeutic trial. Br Med J (1955) 19.22

Serial biopsy in ulcerative colitis. Br Med J (1955) 5.63

Surgical treatment of ulcerative colitis. Br Med J (1961) 2.55

Clinical implications of mucosal healing for the management of IBD. Nat Rev Gastroenterol Hepatol (2009) 2.27

Predicting outcome in severe ulcerative colitis. Gut (1996) 1.99

Patients with active inflammatory bowel disease lack immature peripheral blood plasmacytoid and myeloid dendritic cells. Gut (2005) 1.27

Rectal corticosteroids versus alternative treatments in ulcerative colitis: a meta-analysis. Gut (1997) 1.14

Incidence of inflammatory bowel disease in north west Greece: rarity of Crohn's disease in an area where ulcerative colitis is common. Gut (1994) 1.14

Relationship between the tumor necrosis factor alpha polymorphism and the serum C-reactive protein levels in inflammatory bowel disease. Immunogenetics (2003) 1.01

Timing of surgery in Crohn's disease: a key issue in the management. World J Gastroenterol (2008) 0.98

COMPARISON OF ORAL AND RECTAL STEROIDS IN THE TREATMENT OF PROCTOCOLITIS. Proc R Soc Med (1964) 0.96

Role of endoscopy in predicting the disease course in inflammatory bowel disease. World J Gastroenterol (2010) 0.93

A comprehensive review of inflammatory bowel disease focusing on surgical management. J Korean Soc Coloproctol (2012) 0.91

Aetiology of ulcerative colitis. Gut (1969) 0.91

How I do it. Medical management of severe ulcerative colitis. Int J Colorectal Dis (1988) 0.88

Colonoscopic evaluation in ulcerative colitis. Gastroenterol Rep (Oxf) (2014) 0.85

Cold-reactive lymphocytotoxins in Crohn's disease and ulcerative colitis. I. Incidence and characterization. Clin Exp Immunol (1982) 0.85

Infliximab extends the duration until the first surgery in patients with Crohn's disease. Biomed Res Int (2013) 0.85

Predictors of Thiopurine Treatment Failure in Biologic-Naïve Ulcerative Colitis Patients. Dig Dis Sci (2015) 0.84

Activated eosinophils in association with enteric nerves in inflammatory bowel disease. PLoS One (2013) 0.84

Clinical outcomes and predictive factors for response after the first course of corticosteroid therapy in patients with Crohn's disease. Gut Liver (2013) 0.83

Medical treatment of ulcerative colitis. Postgrad Med J (1984) 0.83

Immunosuppressive therapies for inflammatory bowel disease. World J Gastroenterol (2014) 0.81

The controlled trial. Postgrad Med J (1984) 0.81

Drug therapy of ulcerative colitis. Br J Clin Pharmacol (1992) 0.81

Effects of an Oral Supplementation of Germinated Barley Foodstuff on Serum CRP Level and Clinical Signs in Patients with Ulcerative Colitis. Health Promot Perspect (2014) 0.79

Management of acute severe ulcerative colitis. World J Gastrointest Pathophysiol (2014) 0.79

A Saudi Gastroenterology association position statement on the use of tumor necrosis factor-alfa antagonists for the treatment of inflammatory bowel disease. Saudi J Gastroenterol (2015) 0.77

Efficacy and Safety of Beclomethasone Dipropionate versus 5-Aminosalicylic Acid in the Treatment of Ulcerative Colitis: A Systematic Review and Meta-Analysis. PLoS One (2016) 0.77

II. Medical treatment of inflammatory bowel disease. Calif Med (1973) 0.77

Review and clinical perspectives for the use of infliximab in ulcerative colitis. Can J Gastroenterol (2008) 0.77

Impaired humoral immune response against mycobacterial 65-kDa heat shock protein (HSP65) in patients with inflammatory bowel disease. Dig Dis Sci (2002) 0.76

Nilotinib-mediated mucosal healing in a rat model of colitis. World J Gastroenterol (2013) 0.76

The mRNA level of the transforming growth factor β1 gene, but not the amount of the gene product, can be considered as a potential prognostic parameter in inflammatory bowel diseases in children. Int J Colorectal Dis (2012) 0.76

Local corticosteroid treatment in severe attacke of ulcerative colitis. Br Med J (1960) 0.76

Medical treatment of inflammatory bowel disease: new therapies, new drugs. CMAJ (1987) 0.75

Quantitative ultrasound does not identify patients with an inflammatory disease at risk of vertebral deformities. BMC Musculoskelet Disord (2008) 0.75

How to read a clinical trial paper: a lesson in basic trial statistics. Gastroenterol Hepatol (N Y) (2012) 0.75

ANNOTATIONS. Br Med J (1955) 0.75

Severe ulcerative colitis: at what point should we define resistance to steroids? World J Gastroenterol (2008) 0.75

NON-SPECIFIC enterocolitis. Br Med J (1955) 0.75

Articles by these authors

Cortisone in ulcerative colitis; final report on a therapeutic trial. Br Med J (1955) 19.22

Treatment of ulcerative colitis with local hydrocortisone. Br Med J (1956) 9.21

THE COURSE AND PROGNOSIS OF ULCERATIVE COLITIS. III. COMPLICATIONS. Gut (1964) 8.63

The irritable colon syndrome. A study of the clinical features, predisposing causes, and prognosis in 130 cases. Q J Med (1962) 8.19

THE INTRALUMINAL PRESSURE PATTERNS IN DIVERTICULOSIS OF THE COLON. I. RESTING PATTERNS OF PRESSURE. II. THE EFFECT OF MORPHINE. Gut (1964) 7.25

THE COURSE AND PROGNOSIS OF ULCERATIVE COLITIS. Gut (1963) 6.34

Serial biopsy in ulcerative colitis. Br Med J (1955) 5.63

Biopsy studies in ulcerative colitis. Br Med J (1956) 4.59

HOOKWORM DISEASE IN IMMIGRANTS. Br Med J (1964) 4.45

SMALL-INTESTINAL AND GASTRIC ABNORMALITIES IN ULCERATIVE COLITIS. Br Med J (1965) 4.02

Stilboestrol, phenobarbitone, and diet in chronic duodenal ulcer. A factorial therapeutic trial. Br Med J (1960) 4.00

Comparison of corticosteroid and sulphasalazine therapy in ulcerative colitis. Br Med J (1962) 3.95

SMALL-INTESTINAL AND GASTRIC CHANGES IN ULCERATIVE COLITIS: A BIOPSY STUDY. Br Med J (1964) 3.94

Carcinoma of the stomach. Br Med J (1952) 3.83

Human colonic motility: a comparative study of normal subjects, patients with ulcerative colitis, and patients with the irritable colon syndrome. I. Resting patterns of motility. Gastroenterology (1961) 3.78

Cortisone and corticotrophin in ulcerative colitis. Br Med J (1959) 3.69

Treatment of ulcerative colitis with local hydrocortisone hemisuccinate sodium; a report on a controlled therapeutic trial. Br Med J (1958) 3.39

PULMONARY EMBOLISM. Br Med J (1963) 3.33

Circulating antibodies to milk proteins in ulcerative colitis. Br Med J (1961) 3.23

Heinz-body anaemia due to salicylazosulphapyridine. Lancet (1958) 3.17

Treatment of aphthous ulceration of the mouth. Br Med J (1958) 3.14

Ulcerative colitis provoked by milk. Br Med J (1961) 3.11

THE INTRALUMINAL PRESSURE PATTERNS IN DIVERTICULOSIS OF THE COLON.3. THE EFFECT OF PROSTIGMINE. IV. THE EFFECT OF PETHIDINE AND PROBANTHINE. Gut (1964) 3.03

PLACE OF A DOUBLE-BARRELLED ILEOSTOMY IN ULCERATIVE COLITIS AND CROHN'S DISEASE OF THE COLON: A PRELIMINARY REPORT. Br Med J (1965) 2.88

An immunological study of coeliac disease and idiopathic steatorrhoea. Serological reactions to gluten and milk proteins. Br Med J (1961) 2.86

Motor activity of the sigmoid colon of humans. A combined study by intraluminal pressure recording and cineradiography. Gastroenterology (1962) 2.85

Prognostic factors in myocardial infarction. Lancet (1957) 2.84

Treatment of ulcerative colitis with local hydrocortisone hemisuccinate sodium. Br Med J (1957) 2.53

SEGMENTATION AND THE LOCALIZATION OF INTRALUMINAL PRESSURES IN THE HUMAN COLON, WITH SPECIAL REFERENCE TO THE PATHOGENESIS OF COLONIC DIVERTICULA. Gastroenterology (1965) 2.48

SEROLOGIC REACTIONS TO GLUTEN AND COW'S MILK PROTEINS IN GASTROINTESTINAL DISEASE. Gastroenterology (1964) 2.42

Surgery in haemophilia; the use of animal antihaemophilic globulin and human plasma in thirteen cases. Lancet (1957) 2.37

EFFECT OF MORPHINE, PROSTIGMINE, PETHIDINE, AND PROBANTHINE ON THE HUMAN COLON IN DIVERTICULOSIS STUDIED BY INTRALUMINAL PRESSURE RECORDING AND CINERADIOGRAPHY. Gut (1965) 2.25

A CONTROLLED THERAPEUTIC TRIAL OF VARIOUS DIETS IN ULCERATIVE COLITIS. Br Med J (1965) 2.23

Systemic and local corticosteroid therapy in ulcerative colitis. Br Med J (1960) 2.15

Changes in the blood after partial gastrectomy with special reference to vitamin B12. I. Serum vitamin B12, haemoglobin, serum iron, and bone marrow. Q J Med (1962) 2.14

CROSBY SMALL-INTESTINAL CAPSULE WITH RADIO-OPAQUE TUBE AND LATEX SHEATH. Gut (1965) 2.13

HYPOCHROMIC ANAEMIA. A RETROSPECTIVE STUDY AND FOLLOW-UP OF 378 IN-PATIENTS. Q J Med (1965) 2.11

Human colonic motility: a comparative study of normal subjects, patients with ulcerative colitis, and patients with the irritable colon syndrome. III. Effects of emotions. Gastroenterology (1961) 2.09

Human colonic motility: a comparative study of normal subjects, patients with ulcerative colitis, and patients with the irritable colon syndrome. II. The effect of prostigmin. Gastroenterology (1961) 2.07

Suppository treatment of haemorrhagic proctitis. Br Med J (1959) 2.05

A review of the dietetic factors in liver disease; dietary cirrhosis and necrosis of the liver. Br Med J (1947) 1.97

Results of three years' experience with microbiological assay of vitamin B12 in serum. Br Med J (1958) 1.95

Prognostic factors in myocardial infarction. Lancet (1957) 1.89

Haematemesis, with special reference to peptic ulcer. Br Med J (1955) 1.89

ABNORMALITIES OF THE SACRO-ILIAC JOINTS AND UVEITIS IN ULCERATIVE COLITIS. Q J Med (1965) 1.70

Treatment of ulcerative colitis with local hydrocortisone. Proc R Soc Med (1958) 1.62

Abnormal epithelial cells in ulcerative colitis. Br Med J (1956) 1.58

Megaloblastic anaemia of pregnancy and the puerperium. Br Med J (1955) 1.56

CIRCULATING ANTIBODIES TO DIETARY PROTEINS IN ULCERATIVE COLITIS. Br Med J (1965) 1.54

Excretion of formiminoglutamic acid as an index of folic-acid deficiency. Lancet (1959) 1.54

The augmented histamine test with special reference to achlorhydria. Gut (1960) 1.45

The excretion of small doses of folic acid. Br Med J (1951) 1.45

Simple gastric ulcer and carcinoma. Br Med J (1951) 1.44

Megaloblastic anaemia following partial gastrectomy and gastro-enterostomy. Br J Haematol (1955) 1.43

The lability of human fibrinolysin. Clin Sci (Lond) (1953) 1.41

Effect of food on absorption of radioactive vitamin B12. Lancet (1961) 1.40

The study of erythropoiesis using tracer quantities of radioactive iron. Br J Haematol (1956) 1.31

The effect of iron deficiency on the stomach of the rat. Br J Nutr (1961) 1.30

Intravenous pro-banthine in diagnostic radiology of the gastrointestinal tract, with special reference to colonic disease. Br J Radiol (1960) 1.29

Potential dangers of morphine in acute diverticulitis of the colon. Br Med J (1963) 1.25

The alimentary tract of rats with intestinal culs-de-sac. Br J Exp Pathol (1950) 1.24

The utilisation of folic acid given by mouth. Clin Sci (Lond) (1952) 1.22

Diagnostic pneumoperitoneum. Br Med J (1955) 1.14

Some aspects of the pathology of anaemia. II. Investigation of Castle's hypothesis. Br Med J (1961) 1.12

The clinical association of macrocytic anemia with intestinal stricture and anastomosis. Blood (1949) 1.10

Diabetes mellitus and pernicious anaemia. Br Med J (1963) 1.09

The irritable colon syndrome. Clin Radiol (1963) 1.09

Noninfective pseudomembranous colitis following antibiotic therapy. Am J Dig Dis (1960) 1.08

Changes in the blood after partial gastrectomy with special reference to vitamin B12. II. The cause of the fall in serum vitamin B12. Q J Med (1962) 1.06

Acrosclerosis. Br Med J (1951) 1.06

Hereditary capillary purpura (Von Willebrand's disease). Q J Med (1958) 1.06

Some metabolic and haematological effects of oesophagojejunostomy with by-pass of the stomach. Gut (1961) 1.05

Colonic motility. A critical review of methods and results. Am J Med (1961) 1.05

The blood in pregnancy. J Obstet Gynaecol Br Emp (1962) 1.04

Intestinal macrocytic anaemia. Br Med J (1952) 1.03

Observations on vitamin-B12 absorption in the rat. Br J Haematol (1958) 1.02

Some aspects of the pathology of anaemia. I. Theory of maturation arrest. Br Med J (1961) 1.02

Intrinsic factor in the pyloric and duodenal secretions of the pig. Lancet (1954) 1.02

Tubeless gastric analysis. Br Med J (1958) 1.01

ANAEMIA ASSOCIATED WITH UNEXPLAINED OCCULT BLOOD LOSS. Br Med J (1964) 1.00

Haematemesis in the elderly. J Am Geriatr Soc (1956) 0.99

Arthur Quinton Wells, 22nd June 1896-9th October 1956. J Pathol Bacteriol (1958) 0.97

Recent work on B vitamins in the blood and gastrointestinal tract, especially in relation to human diseases. Br Med Bull (1956) 0.97

Recent work on leukaemia in man. Br Med J (1957) 0.97

Treatment of hay-fever with local hydrocortisone hemisuccinate sodium. Br Med J (1958) 0.97

Circulating antibodies to cow's milk proteins and gluten in the newborn. Br Med J (1962) 0.96

Primary hypertrophic pyloric stenosis in the adult. Br J Radiol (1958) 0.95

Radioactive vitamin B12 after partial gastrectomy. Lancet (1963) 0.92

STUDIES ON THE SERUM IRON-BINDING CAPACITY. J Clin Pathol (1965) 0.90

An apparently homogeneous substance with intrinsic-factor activity associated with cell particles from human stomach. Lancet (1955) 0.89

The utilisation of folinic acid injected intravenously. Clin Sci (Lond) (1953) 0.89

Immunological reactions in gastrointestinal disease: a review. Gut (1962) 0.88

Diagnostic pneumoperitoneum. Br J Radiol (1957) 0.85

The utilisation of folic acid in anaemia and leukaemia. Clin Sci (Lond) (1953) 0.85

The development of pernicious anaemia. Acta Haematol (1961) 0.84

The histamine test meal in the rat. Gut (1961) 0.83

Conversion of folic acid to the citrovorum factor in health and pernicious anaemia. Br Med J (1952) 0.82

Trial of tween 80 in patients with loss of weight after partial gastrectomy. Lancet (1951) 0.82